Pathophysiological mechanisms linking depression and atherosclerosis: An overview

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 4, 2012, Pages 775-782

  Pizzi, C ^a   Santarella, L ^a   Costa, M G ^a   Manfrini, O ^a   Flacco, M E ^b   Capasso, L ^b   Chiarini, S ^b   Di Baldassarre, A ^b   Manzoli, Lamberto ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Aatherosclerosis; Autonomic nervous system; Coronary syndrome; Depression; Inflammation markers

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; SERTRALINE;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ISCHEMIC HEART DISEASE; LIPID METABOLISM; PATHOPHYSIOLOGY; PLATELET REACTIVITY; SEX DIFFERENCE; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; PHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT; VASCULAR ENDOTHELIUM;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SEX CHARACTERISTICS;

EID: 84876489941     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics 2010 Update: a report from the American Heart Association. Circulation 2010; 121:46-215.
2. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008; 29:1110-17. (Pubitemid 351844893)
3. Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, Costa GM. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010; 212:292-8.
4. Sher Y, Lolak S, Maldonado JR. The impact of depression in heart disease. Curr Psychiatry Rep 2010; 12:255-64.
5. Elovainio M, Keltikangas-Järvinen L, Kivimäki M, et al. Depressive symptoms and carotid artery intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Psychosom Med 2005; 67:561-7. (Pubitemid 41033584)
6. Rice SC, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR. Absence of relation between depressive symptoms and carotid intimal medial thickness in the Baltimore Longitudinal Study of Aging. Psychosom Med 2009; 71:70-6.
7. Hamer M, Kivimaki M, Lahiri A, Marmot MG, Steptoe A. Persistent cognitive depressive symptoms are associated with coronary artery calcification. Atherosclerosis 2010; 210:209-13.
8. Schrijvers DM, De Meyer GR, Herman AG, Martinet W. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007; 73:470-80. (Pubitemid 46073944)
9. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 2000; 21:55-89. (Pubitemid 32266068)
10. Akil H, Haskett RF, Young EA, Grunhaus L, Kotun J, Weinberg Y, Greden J, Watson SJ. Multiple HPA profiles in endogenous depression: effect of age and sex on Cortisol and beta-endorphin. Biol Psychiatry 1993; 33:73-85. (Pubitemid 23069190)
11. Thayer JF, Siegle GJ. Neurovisceral integration in cardiac and emotional regulation. EEE Eng Med Biol Mag 2002; 21:24-9.
12. Ablad B, Bjorkman JA, Gustaffson D, Hansson G, Ostlund-Lindquist AM, Pettersson K. The role of sympathetic activation in atherogenesis: effects of beta-blockade. Am Heart J 1988; 116:322-27.
13. Wittstein IS. Depression, anxiety, and platelet reactivity in patients with coronary heart disease. Eur Heart J 2010; 31:1548-50.
14. Gehi A, Musselman D, Otte C, Bruce Royster E, Ali S, Whooley MA. Depression and platelet activation in outpatients with stable coronary heart disease: findings from the Heart and Soul Study. Psychiatry Res 2010; 175:200-4.
15. Conti CM, Fulcheri M. Interlationship between psychology and cytokines. J Biol Regul Homeost Agents 2010; 24:485-90.
16. Celik C, Erdem M, Cayci T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17; 34:372-5.
17. Cooper DC, Tomfohr LM, Milic MS, Natarajan L, Bardwell WA, Ziegler MG, Dimsdale JE. Depressed mood and flow-mediated dilation: a systematic review and meta-analysis. Psychosom Med 2011; 73:360-9.
18. Burg MM, Martens EJ, Collins D, Soufer R. Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med 2011; 73:2-6.
19. Dome P, Teleki Z, Rihmer Z, et al. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry 2009; 14:523-31.
20. Janssen I, Powell LH, Matthews KA, Cursio JF, Hollenberg SM, Sutton-Tyrrell K, Bromberger JT, Everson-Rose SA. Depressive symptoms are related to progression of coronary calcium in midlife women: the Study of Women's Health Across the Nation (SWAN) Heart Study. Am Heart J 2011; 161:1186-91.
21. Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, Costa GM. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther 2009; 86:527-32.
22. De Berardis D, Conti CM, Serroni N, et al. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int J Immunopathol Pharmacol 2010; 23:417-22.
23. Serebruany VL, Suckow RF, Cooper TB, et al. Sertraline Antidepressant Heart Attack Randomized Trial. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 2005; 162:1165-70. (Pubitemid 40770700)
24. Ungvari Z, Pacher P, Koller A. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol 2000; 35:849-54. (Pubitemid 30327512)
25. Pizzi C, Rutjes AW, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 2011; 107:972-9.